Overview

In this Director role, you will lead general value, access, and pricing strategies for Neurology, with a focus on NMOSD. You shape the value proposition and payer strategy across key EU markets, driving launch readiness and lifecycle management. You collaborate with cross-functional teams to secure evidence and enable patient access while navigating payer environments. This is a strategic, high-impact position within a respected Rare Disease organization, offering influence over major market access decisions and evidence generation. You will work in a dynamic, global team and contribute to the Neurology portfolio’s success and patient access goals.

Responsabilidades

- Lead cross-functional development of a differentiated NMOSD value proposition and influence organizational decision-making
- Incorporate evidence generation plans and real-world evidence to strengthen payer value and support country input on endpoints
- Support NMOSD lifecycle management and TPP requirements through governance milestones
- Develop general market access and pricing strategies and partner with country access teams for implementation
- Assess and mitigate pricing and reimbursement risks, shaping country-specific strategies and tools




- Create value, access, and pricing materials to support local P&R; submissions and negotiations
- Update global NMOSD reimbursement dossier and coordinate cross-functional market access readiness
- Represent GVAP in Global Sub-Team and Global Launch Team, guiding local teams and sharing insights
- Lead the Neurology payer working group to disseminate evidence and best practices across markets
- Ensure patient perspective is integrated into payer strategies and negotiations

Requisitos principales

- Deep expertise in global payer, HTA, and reimbursement ecosystems
- Track record of market access and pricing success in rare diseases and Neurology
- Experience with evidence generation and working with payers in the EU and US
- Strong leadership and cross-functional collaboration capabilities
- Ability to translate scientific data into payer-focused value narratives
- 6+ years of drug development or commercialization experience in pharma/biotech

- leadership
- communication
- strategic influence
- HTA and payer strategy
- value proposition development
- RWE planning and evidence generation

📌 Global Pricing & Access Lead, Rare Neurology (Barcelona)
🏢 AstraZeneca
📍 Barcelona